Sources Program #5: Eye Diabetes and Associated Disorders

Eye Diabetes and Associated Disorders encompass a range of ocular complications arising from diabetes mellitus, a chronic metabolic condition affecting blood sugar levels. Retyne Program 5 is dedicated to addressing these specific issues comprehensively, acknowledging the complex interplay between diabetes and ocular health.

Diabetic cataracts are a common complication, characterized by clouding of the eye's lens due to prolonged exposure to high blood sugar levels. Diabetic glaucoma refers to increased intraocular pressure, which can damage the optic nerve and lead to vision loss. Diabetic macular edema (DME) involves swelling of the macula, the central part of the retina, resulting in vision impairment.

Diabetic neuro-ophthalmopathy encompasses various nerve disorders affecting vision, including diabetic papillopathy, which involves swelling of the optic nerve head, and diabetic retinopathy, a leading cause of blindness worldwide. These conditions result from damage to the small blood vessels supplying the retina, leading to leakage, hemorrhages, and eventually, vision loss if left untreated.

Retyne Program 5 utilizes specific frequencies and energy wavelengths tailored to address the underlying pathophysiology of diabetic eye complications. By targeting inflammation, improving blood flow, and promoting tissue regeneration, this program aims to alleviate symptoms, slow disease progression, and preserve vision in individuals with diabetes. The inclusion of frequencies specific to diabetic cataracts, glaucoma, macular edema, neuro-ophthalmopathy, papillopathy, and retinopathy ensures a comprehensive approach to managing these sight-threatening conditions, offering hope for improved ocular health and quality of life.

The Retyne Mask is equipped with a Standard Controller upon shipment, containing 50 frequencies organized into 5 distinct Groups:

For Eye related Diabetes and Associated Disorders, the Retyne mask employs Program #5, categorized as a "General" Group, compatible with themask 's accompanying Controller. The following list enumerates these disorders, along with brief justifications for their inclusion in Program #5.  This Group encompasses specific frequencies or frequency ranges deemed optimal for treating the respective eye disorders.

Bioresonance testing and research have identified specific frequencies within Program #5 that demonstrate efficacy in treating a diverse range of eye disorders, despite their seemingly unrelated nature.  As a result, certain eye disorder frequencies within Program #5 have been included to accommodate these shared frequency characteristics.